These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 19624862)

  • 1. Inhibitory effect of ginsenoside Rg3 combined with gemcitabine on angiogenesis and growth of lung cancer in mice.
    Liu TG; Huang Y; Cui DD; Huang XB; Mao SH; Ji LL; Song HB; Yi C
    BMC Cancer; 2009 Jul; 9():250. PubMed ID: 19624862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effect of ginsenoside Rg3 combined with cyclophosphamide on growth and angiogenesis of ovarian cancer.
    Xu TM; Xin Y; Cui MH; Jiang X; Gu LP
    Chin Med J (Engl); 2007 Apr; 120(7):584-8. PubMed ID: 17442207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Inhibitory Effect of Ginsenoside Rg3 Combined With 5-Fluorouracil on Tumor Angiogenesis and Tumor Growth of Colon Cancer in Mice: An Experimental Study].
    Zhao Y; Deng L; Cao Y; Ma B; Li Y; Xu J; Li H; Huang Y
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2024 Jan; 55(1):111-117. PubMed ID: 38322531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Experimental study on anti-angiogenesis in mice with Lewis lung carcinoma by low-dose of cyclophosphamide combined with ginsenoside Rg3].
    Kang XM; Zhang QY; Tong DD; Zhao W
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2005 Aug; 25(8):730-3. PubMed ID: 16152834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anti-angiogenic effects of low-dose gemcitabine combined with ginsenoside Rg3 on mouse Lewis lung carcinoma].
    Huang X; Hou M; Yi C; Song H
    Zhongguo Fei Ai Za Zhi; 2006 Apr; 9(2):132-6. PubMed ID: 21144297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination therapy of VEGF-trap and gemcitabine results in improved anti-tumor efficacy in a mouse lung cancer model.
    Zhou S; Yang Y; Yang Y; Tao H; Li D; Zhang J; Jiang G; Fang J
    PLoS One; 2013; 8(7):e68589. PubMed ID: 23874680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiangiogenic effect of low-dose cyclophosphamide combined with ginsenoside Rg3 on Lewis lung carcinoma.
    Zhang Q; Kang X; Zhao W
    Biochem Biophys Res Commun; 2006 Apr; 342(3):824-8. PubMed ID: 16499874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ginsenoside Rg3 attenuates tumor angiogenesis via inhibiting bioactivities of endothelial progenitor cells.
    Kim JW; Jung SY; Kwon YH; Lee JH; Lee YM; Lee BY; Kwon SM
    Cancer Biol Ther; 2012 May; 13(7):504-15. PubMed ID: 22406998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ginsenoside Rg3 targets cancer stem cells and tumor angiogenesis to inhibit colorectal cancer progression in vivo.
    Tang YC; Zhang Y; Zhou J; Zhi Q; Wu MY; Gong FR; Shen M; Liu L; Tao M; Shen B; Gu DM; Yu J; Xu MD; Gao Y; Li W
    Int J Oncol; 2018 Jan; 52(1):127-138. PubMed ID: 29115601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Preliminary study for the roles and mechanisms of 20(R)-ginsenoside Rg3 and PEG-PLGA-Rg3 nanoparticles in the Lewis lung cancer mice].
    Geng L; Fan J; Gao QL; Yu J; Hua BJ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Jun; 48(3):496-501. PubMed ID: 27318914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical benefit from EGFR-TKI plus ginsenoside Rg3 in patients with advanced non-small cell lung cancer harboring EGFR active mutation.
    Li Y; Wang Y; Niu K; Chen X; Xia L; Lu D; Kong R; Chen Z; Duan Y; Sun J
    Oncotarget; 2016 Oct; 7(43):70535-70545. PubMed ID: 27655708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effect of Bifidobacterium infantis-mediated sKDR prokaryotic expression system on angiogenesis and growth of Lewis lung cancer in mice.
    Li ZJ; Zhu H; Ma BY; Zhao F; Mao SH; Liu TG; He JP; Deng LC; Yi C; Huang Y
    BMC Cancer; 2012 Apr; 12():155. PubMed ID: 22536942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ginsenoside Rg3 sensitizes human non-small cell lung cancer cells to γ-radiation by targeting the nuclear factor-κB pathway.
    Wang L; Li X; Song YM; Wang B; Zhang FR; Yang R; Wang HQ; Zhang GJ
    Mol Med Rep; 2015 Jul; 12(1):609-14. PubMed ID: 25738799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different combination schedules of gemcitabine with endostar affect antitumor efficacy.
    Peng XC; Qiu M; Wei M; Tan BX; Ge J; Zhao Y; Chen Y; Cheng K; Zhou Y; Wu Y; Gong FM; Li Q; Xu F; Bi F; Liu JY
    Cancer Chemother Pharmacol; 2012 Jan; 69(1):239-46. PubMed ID: 21706279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of low-dose gemcitabine and recombinant quail vascular endothelial growth factor receptor-2 as a vaccine induces synergistic antitumor activities.
    Hou JM; Liu JY; Yang L; Zhao X; Tian L; Ding ZY; Wen YJ; Niu T; Xiao F; Lou YY; Tan GH; Deng HX; Li J; Yang JL; Mao YQ; Kan B; Wu Y; Li Q; Wei YQ
    Oncology; 2005; 69(1):81-7. PubMed ID: 16088235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effect of tumor metastasis in mice by saponins, ginsenoside-Rb2, 20(R)- and 20(S)-ginsenoside-Rg3, of red ginseng.
    Mochizuki M; Yoo YC; Matsuzawa K; Sato K; Saiki I; Tono-oka S; Samukawa K; Azuma I
    Biol Pharm Bull; 1995 Sep; 18(9):1197-202. PubMed ID: 8845804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ginsenoside Rg3 suppresses the growth of gemcitabine-resistant pancreatic cancer cells by upregulating lncRNA-CASC2 and activating PTEN signaling.
    Zou J; Su H; Zou C; Liang X; Fei Z
    J Biochem Mol Toxicol; 2020 Jun; 34(6):e22480. PubMed ID: 32104955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antitumor effects of interferon-gamma-inducible protein 10 combined with gemcitabine].
    Mei K; Tian L; Wei YQ; Li J; Wen YJ; Kan B; Deng HX
    Ai Zheng; 2005 Apr; 24(4):397-402. PubMed ID: 15820059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB-regulated gene products.
    Kunnumakkara AB; Guha S; Krishnan S; Diagaradjane P; Gelovani J; Aggarwal BB
    Cancer Res; 2007 Apr; 67(8):3853-61. PubMed ID: 17440100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic anti-tumor effect of recombinant chicken fibroblast growth factor receptor-1-mediated anti-angiogenesis and low-dose gemcitabine in a mouse colon adenocarcinoma model.
    Zheng SJ; Zheng SP; Huang FY; Jiao CL; Wu RL
    World J Gastroenterol; 2007 May; 13(17):2484-9. PubMed ID: 17552033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.